Testing a new medicine for year-round allergies
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This trial tests a new nasal spray for people with perennial (year-round) allergic rhinitis. It aims to see if the medicine works well and is safe compared to other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had allergy symptoms (like sneezing, stuffy nose) from allergens that are around all year (like dust mites or pet dander) for at least 9 out of the last 12 months.
- You do not have asthma that requires regular steroid treatment, or uncontrolled asthma.
- You have not had nasal surgery in the past 6 months or any nose structure problem that blocks airflow.
- You have not taken allergy shots or immunotherapy in the last 2 years.
- You do not have a current or recent cold, sinus infection, or other nasal condition like chronic sinusitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injection called GR1802 for people with seasonal allergic rhinitis (hay fever) that isn't well controlled by standard treatments. It aims to see if this medicine can help reduce symptoms during pollen season.
This study tests a new nasal spray (ALDP001) in adults with seasonal allergies to ragweed. It aims to find the best dose and how often to use it.
This study tests a new injection called JYB1904 for people with year-round nasal allergies. It may help reduce symptoms like sneezing, stuffy nose, and runny nose.
This trial tests if a special probiotic blend can help people with year-round allergic rhinitis (nasal allergies) caused by common indoor allergens like dust mites, cat, or dog dander. Volunteers will take the probiotic daily and track their symptoms.
This trial tests a new medicine called DW1807 for people who have both year-round allergies (like dust mites or pet dander) and asthma. It aims to see if it helps control nasal symptoms and is safe to use.
This trial tests an experimental antibody (IL4Rα monoclonal antibody) for people with seasonal allergic rhinitis (hay fever) that is not well controlled by standard treatments like nasal steroid sprays. The goal is to see if this new treatment can help reduce allergy symptoms during pollen season.
Hear when a new Rhinitis, Allergic, Perennial trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.